Jubilant DraxImage is dedicated to providing radiopharmaceuticals for the diagnosis and treatment of a variety of diseases. We invite you to learn more about these areas and how our products are used by healthcare professionals to care for their patients.
Clinical nuclear medicine studies play an important role in the non-invasive evaluation of cardiac physiology and function including myocardial perfusion. The use of nuclear cardiovascular examinations permits the sensitive detection and diagnosis of numerous cardiac abnormalities as well as the determination of the functional consequences and prognosis of coronary artery disease.
Imaging of myocardial perfusion with radiopharmaceuticals is the most commonly performed cardiac examination in clinical nuclear medicine practice. Its primary goal is to determine the adequacy of blood flow to the myocardium, especially in conjunction with exercise or pharmacologic stress for the detection, localization and evaluation of coronary artery disease (CAD).
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection
DRAXIMAGE® Sestamibi is indicated for: myocardial perfusion imaging for the diagnosis and localization of myocardial infarction diagnosis and localization of ischaemic heart disease and coronary artery disease assessment of global ventricular function by the first pass technique.
The kit consists of reaction vials which contain the sterile, non-pyrogenic, non-radioactive ingredients necessary to produce Technetium Tc 99m Sestamibi Injection for diagnostic use by intravenous injection. Available in kits containing 10 reaction vials.
This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate product labeling.